Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
2
×
startups
ajay royan
ec healthtech
ec investor survey
events
frederic moll
health
johnson & johnson
mental health
psychedelics
tc
techcrunch disrupt sf 2019
venture
What
come
2
×
ajay
anna
auris
billion
ceo
colorful
company
depends
difficult
disrupt
entrepreneurs
far
frederic
future
hansen
heim
household
include
industry
intuitive
inventors
investor
investors
j
lead
look
manufacturer
medical
medicines
moll
moll’s
months
old
originally
past
predict
psychedelic
psychedelics
publicly
Language
unset
Current search:
come
×
photo
×
biotech
×
@techcrunch.com
11 months ago
11 investors predict a colorful, if difficult, future for psychedelic startups
@techcrunch.com
4 years ago
After selling Auris for $3.4 billion to J&J, CEO Frederic Moll and lead investor Ajay Royan come to Disrupt
